Disruption of aldose reductase gene (Akr1b1) causes defect in urinary concentrating ability and divalent cation homeostasis

被引:32
|
作者
Aida, K
Ikegishi, Y
Chen, J
Tawata, M
Ito, S
Maeda, S
Onaya, T [1 ]
机构
[1] Yamanashi Med Univ, Dept Internal Med 3, Yamanashi 4093898, Japan
[2] Yamanashi Med Univ, Dept Biochem 1, Yamanashi 4093898, Japan
关键词
aldose reductase; AKR1B1; gene targeting; hypercalcemia; hypercalciuria; urinary concentrating ability; divalent cation homeostasis;
D O I
10.1006/bbrc.2000.3648
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aldose reductase (AKR1B1) is the first enzyme in the polyol pathway through which glucose is converted to sorbitol, and has been implicated in the etiology of diabetic complications. However, its physiological role is still not well understood. In the kidney, AKR1B1 is quite abundant in the collecting tubule cells and thought to provide protection against hypertonic environment. We report here that the mice lacking AKR1B1 showed hypercalcemia, hypercalcemia, hypermagnesemia, and reduced ability to concentrate urine, suggesting a new physiological role of AKR1B1 in divalent cation homeostasis. (C) 2000 Academic Press.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 50 条
  • [1] Association of aldose reductase gene (AKR1B1) polymorphism with diabetic retinopathy
    Kaur, Navdeep
    Vanita, Vanita
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 121 : 41 - 48
  • [2] The association of aldose reductase gene (AKR1B1) polymorphisms with diabetic neuropathy in adolescents
    Donaghue, KC
    Margan, SH
    Chan, AKF
    Holloway, B
    Silink, M
    Rangel, T
    Bennetts, B
    DIABETIC MEDICINE, 2005, 22 (10) : 1315 - 1320
  • [3] Variants in the gene encoding aldose reductase (AKR1B1) and diabetic nephropathy in American Indians
    Wolford, JK
    Yeatts, K
    Eagle, AR
    Nelson, R
    Knowler, WC
    Hanson, RL
    DIABETES, 2005, 54 : A203 - A203
  • [4] Variants in the gene encoding aldose reductase (AKR1B1) and diabetic nephropathy in American Indians
    Wolford, JK
    Yeatts, KA
    Eagle, ARR
    Nelson, RG
    Knowler, WC
    Hanson, RL
    DIABETIC MEDICINE, 2006, 23 (04) : 367 - 376
  • [5] Selective Up-Regulation of MAPK Signaling by Aldose Reductase (AKR1B1)
    Pal, A.
    Palla, S.
    Ruzycki, P. A.
    Reddy, B. G.
    Petrash, J. M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [6] Anterior Plaque Formation Phenotype Linked to Activation of Aldose Reductase (AKR1B1)
    Ruzycki, P. A.
    Zablocki, G. J.
    Palla, S.
    Ammar, D. A.
    Reddy, B. G.
    Petrash, J. M.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [7] The role of aldose reductase gene (AKR1B1) polymorphisms in decline in nerve function in adolescents with type 1 diabetes
    Donaghue, KC
    Thamotharampillai, K
    Chan, AKF
    Cusumano, J
    Craig, M
    Silink, M
    Bennetts, B
    DIABETES, 2005, 54 : A7 - A7
  • [8] The Human Aldose Reductase AKR1B1 Qualifies as the Primary Prostaglandin F Synthase in the Endometrium
    Bresson, Eva
    Boucher-Kovalik, Sofia
    Chapdelaine, Pierre
    Madore, Eric
    Harvey, Nathalie
    Laberge, Philippe Y.
    Leboeuf, Mathieu
    Fortier, Michel A.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (01): : 210 - 219
  • [9] (-)-Kusunokinin as a Potential Aldose Reductase Inhibitor: Equivalency Observed via AKR1B1 Dynamics Simulation
    Tanawattanasuntorn, Tanotnon
    Thongpanchang, Tienthong
    Rungrotmongkol, Thanyada
    Hanpaibool, Chonnikan
    Graidist, Potchanapond
    Tipmanee, Varomyalin
    ACS OMEGA, 2021, 6 (01): : 606 - 614
  • [10] The role of aldose reductase gene (AKR1B1) polymorphisms in neurophysiological decline in adolescents with type 1 diabetes - a seven-year longitudinal study
    Thamotharampillai, Keerthi
    Craig, Maria
    Chan, Albert
    Bennets, Bruce
    Silink, Martin
    Cusumano, Janine
    Donaghue, Kim
    HORMONE RESEARCH, 2006, 65 : 16 - 16